AXTA, BMG0750C1082

Axalta Coating Systems stock holds steady as UK CMA probes AkzoNobel deal

Published on 09/18/2026 at 21:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Axalta Coating Systems stock is trading in a stable range as of mid-September 2026 while regulators in the UK review AkzoNobel’s planned sale of its North American paints business to Axalta. The CMA probe adds a regulatory risk alongside existing analyst price targets and consensus views on Axalta Coating Systems stock.

AXTA, BMG0750C1082, Illustration mit AI erstellt.
AXTA, BMG0750C1082, Illustration mit AI erstellt.

Axalta Coating Systems stock (ISIN BMG0750C1082) is trading in a relatively steady pattern as of mid-September 2026, with investors weighing the company’s planned acquisition of AkzoNobel’s North American paints business alongside existing analyst valuations and regulatory scrutiny from the UK Competition and Markets Authority (CMA) as of September 18, 2026.

Regulatory probe into AkzoNobel-Axalta deal

As of September 18, 2026, market commentary highlights that the UK CMA has opened a probe into the planned transaction in which AkzoNobel would sell a North American paints business to Axalta Coating Systems, adding regulatory uncertainty to Axalta Coating Systems stock even though the deal is still at an early review stage.Newsquawk In that European market briefing dated September 18, 2026, the AkzoNobel-Axalta transaction is described as facing a UK CMA probe, underlining that competition authorities are actively reviewing the potential impact of the deal on the coatings and paints market in the region.Newsquawk For Axalta Coating Systems stock, this regulatory step is a key risk factor because a negative ruling could delay or reshape the strategic expansion the company is pursuing through the acquisition.

The CMA probe comes against a backdrop of broader macroeconomic caution in global equities in mid-September 2026, with some investors more sensitive to regulatory and execution risks in transaction-driven stories.Reuters In that environment, Axalta Coating Systems’ planned AkzoNobel deal and its review by the UK CMA serve as an important narrative for the stock, because both revenue synergies and potential cost efficiencies from the transaction remain subject to regulatory clearance before they can be realized.

Recent earnings and fundamentals context

Axalta Coating Systems reported its most recent quarterly figures earlier in 2026, with financial portals summarizing that the company generated several hundred million dollars in revenue for the quarter and maintained profitability, although the exact values and reporting period are not detailed in the current week’s compact search results; these earlier results therefore serve only as historical context and not as current core figures for Axalta Coating Systems stock in mid-September 2026. Given the recency rules, only figures from the latest quarter or fiscal year within the last 24 months and clearly labeled as such would count as current, and the available snippets within this week’s filtered sources do not provide concrete, periodized numbers for Axalta Coating Systems’ revenue or earnings that can be fully substantiated and dated in Q2 2026 or fiscal year 2025.

Investor-interest summaries for Axalta Coating Systems stock compiled during mid-September 2026 point to a mix of Buy and Hold recommendations from analysts, with an average price target in the mid-30-dollar range used as a valuation reference in some holdings-overview articles.MarketBeat In that MarketBeat overview dated September 18, 2026, Axalta Coating Systems is described as carrying an average consensus price target of USD 36.85, based on coverage where several analysts rate the stock Buy and others Hold, providing a quantified comparison against the latest trading levels and suggesting modest upside potential from recent prices if the company executes on its strategy and regulatory risks around the AkzoNobel deal are resolved favorably.

The same MarketBeat summary reports that previous coverage included KeyCorp initiating Axalta Coating Systems stock at Overweight with a USD 47.00 price target and Mizuho lifting its price target from USD 32.00 to USD 39.00 while assigning an Outperform rating.MarketBeat This set of targets provides a further quantified comparison: the USD 39.00 target from Mizuho stands USD 6.37 above the consensus target of USD 32.63 cited in the broader stock-portal context and USD 2.15 above the USD 36.85 average target, highlighting that some houses see more upside than the consensus, while others remain more cautious.

Analyst positioning and valuation comparison

MarketBeat’s data also highlight that Axalta Coating Systems stock carries a broad analyst base, with five analysts assigning Buy ratings and nine analysts issuing Hold ratings in the latest consensus overview.MarketBeat This distribution of views results in an overall Hold consensus, which investors can compare numerically against the USD 36.85 average price target and the latest trading price cited in stock-portal figures around the low-30-dollar range; the gap between these levels quantifies the potential upside suggested by analysts, while the Hold tilt reflects some caution about earnings momentum and transaction risks.

In addition, stock-portal snapshots for Axalta Coating Systems around mid-September 2026 present a recent quote of approximately USD 32.63, with the figure used in multi-company overviews of industrial and specialty chemical names, though without full timestamp detail in the current week’s compact results.Yahoo Finance Using the consensus price target of USD 36.85 from MarketBeat as of September 18, 2026, this implies that Axalta Coating Systems stock is trading roughly USD 4.22 below the analyst average and about 11.5 percent under the consensus target, a quantified valuation gap that investors may see as potential upside if fundamentals and the AkzoNobel transaction develop positively.

For investors, the key question is whether Axalta Coating Systems can convert the planned acquisition of AkzoNobel’s North American paints business into tangible revenue and margin gains while managing the CMA probe and other regulatory reviews, because the analyst targets and Hold consensus incorporate both expected benefits and the risk that the deal might be delayed or modified before completion.Newsquawk

Axalta Coating Systems stock price and market data

As of the latest completed trading session visible in mid-September 2026, Axalta Coating Systems stock on its primary US exchange was quoted at around USD 32.63, placing it below the USD 36.85 consensus analyst price target and well under the highest individual target of USD 47.00 cited in MarketBeat’s overview.MarketBeatYahoo Finance That price level indicates that the shares are trading several dollars below targets, which could be interpreted as the market discounting regulatory and macro risks or simply reflecting cautious sentiment on the near-term earnings trajectory.

Specific data on Axalta Coating Systems’ 52-week high and low, market capitalization and daily volume for the latest completed trading day are summarized in stock-portal views used by investors in mid-September 2026, but within this week-filtered result set the detailed numeric values and exact timestamps are not fully enumerated; consequently, the most reliable quantified comparison available is the gap between the USD 32.63 trading level cited and the USD 36.85 consensus price target and USD 47.00 higher individual target, which shows that Axalta Coating Systems stock trades meaningfully below both reference levels as of mid-September 2026.MarketBeat

Axalta Coating Systems stock - key data

  • Company: Axalta Coating Systems Ltd.
  • ISIN: BMG0750C1082
  • Ticker: AXTA
  • Trading venue: NYSE
  • Sector / Industry: Materials / Specialty Chemicals
  • Index membership: S&P 500

More news and analyses on Axalta Coating Systems stock

Disclaimer...

en | BMG0750C1082 | AXTA | boerse | 70128277 | bgmi